Clinical Trial Update: A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV [Phase 1]

View source ↗

Summary

Phase 1 trial update on an HIV envelope trimer vaccine candidate (N332-GT5 gp140) adjuvanted with SMNP in adults without HIV. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• N332-GT5 gp140 envelope trimer vaccine with SMNP adjuvant (HIV-1 envelope trimer N332-GT5 gp140 with SMNP adjuvant)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: COMPLETED